DK0918874T3 - Selvreplikerende episomale ekspressionsvektorer, som giver vævsspecifik genekspression - Google Patents

Selvreplikerende episomale ekspressionsvektorer, som giver vævsspecifik genekspression

Info

Publication number
DK0918874T3
DK0918874T3 DK97937661T DK97937661T DK0918874T3 DK 0918874 T3 DK0918874 T3 DK 0918874T3 DK 97937661 T DK97937661 T DK 97937661T DK 97937661 T DK97937661 T DK 97937661T DK 0918874 T3 DK0918874 T3 DK 0918874T3
Authority
DK
Denmark
Prior art keywords
self
specific gene
provide tissue
gene expression
expression vectors
Prior art date
Application number
DK97937661T
Other languages
Danish (da)
English (en)
Inventor
Michael Antoniou
Franklin Geradus Grosveld
Original Assignee
Medical Res Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9617214.3A external-priority patent/GB9617214D0/en
Application filed by Medical Res Council filed Critical Medical Res Council
Application granted granted Critical
Publication of DK0918874T3 publication Critical patent/DK0918874T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16241—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16243—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/108—Plasmid DNA episomal vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/46—Vector systems having a special element relevant for transcription elements influencing chromatin structure, e.g. scaffold/matrix attachment region, methylation free island

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Magnetic Ceramics (AREA)
  • Peptides Or Proteins (AREA)
  • Telephonic Communication Services (AREA)
DK97937661T 1996-08-16 1997-08-18 Selvreplikerende episomale ekspressionsvektorer, som giver vævsspecifik genekspression DK0918874T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9617214.3A GB9617214D0 (en) 1996-08-16 1996-08-16 Vector
US2504096P 1996-08-28 1996-08-28
PCT/GB1997/002213 WO1998007876A2 (en) 1996-08-16 1997-08-18 Self-replicating episomal expression vectors conferring tissue-specific gene expression

Publications (1)

Publication Number Publication Date
DK0918874T3 true DK0918874T3 (da) 2001-05-14

Family

ID=26309883

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97937661T DK0918874T3 (da) 1996-08-16 1997-08-18 Selvreplikerende episomale ekspressionsvektorer, som giver vævsspecifik genekspression

Country Status (11)

Country Link
EP (1) EP0918874B1 (es)
JP (1) JP2000516472A (es)
AT (1) ATE199570T1 (es)
AU (1) AU725474B2 (es)
CA (1) CA2263796A1 (es)
DE (1) DE69704206T2 (es)
DK (1) DK0918874T3 (es)
ES (1) ES2157084T3 (es)
GR (1) GR3035838T3 (es)
PT (1) PT918874E (es)
WO (1) WO1998007876A2 (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6399383B1 (en) * 1997-10-28 2002-06-04 Maxygen, Inc. Human papilloma virus vectors
ATE539161T1 (de) 1998-07-21 2012-01-15 Millipore Corp Ein ein allgegenwärtiges chromatin-öffnendes element (ucoe) enthaltendes polynucleotid
EP2348118A1 (en) 1998-07-21 2011-07-27 Millipore Corporation A polynucleotide comprising a ubiquitous chromatin opening element (ucoe)
US6417002B1 (en) 1999-02-11 2002-07-09 Pharmacopeia, Inc. Method for maintenance and selection of episomes
DE19942149A1 (de) * 1999-09-03 2001-03-15 Daniele Zink Verfahren zur Expression von exogenen Sequenzen in Säugerzellen
CN1418224A (zh) 2000-03-02 2003-05-14 Ml实验室公开有限公司 Tcf效应元件
AU9006701A (en) 2000-09-20 2002-04-02 Cobra Therapeutics Ltd Polynucleotide
JP2005500019A (ja) 2001-04-05 2005-01-06 エムエル ラボラトリーズ ピーエルシー 改良された遺伝子発現
US7812148B2 (en) 2001-04-05 2010-10-12 Millipore Corporation Vectors comprising CpG islands without position effect varigation and having increased expression
FI116851B (fi) 2001-05-03 2006-03-15 Fit Biotech Oyj Plc Ilmentämisvektori, sen käyttöjä ja menetelmä sen valmistamiseksi sekä sitä sisältäviä tuotteita
BRPI0209416A8 (pt) * 2001-05-03 2018-05-08 Fit Biotech Oyj Plc novos vetores de expressão e uso dos mesmos
GB2384001B (en) 2001-12-14 2004-02-04 Asterion Ltd Chimeric growth hormone-growth hormone receptor proteins
EP1558638B1 (en) 2002-10-07 2009-03-11 Ludwig Institute for Cancer Research Ltd P53 binding polypeptide
DE602004027789D1 (de) 2003-02-01 2010-08-05 Millipore Corp Verbesserte genetische elemente für eine erhöhte genexpression
FI116068B (fi) 2003-09-15 2005-09-15 Fit Biotech Oyj Plc Uusi selektiojärjestelmä, siinä käyttökelpoinen vektori, bakteerisolukantoja sekä menetelmä solujen valikoimiseksi
GB0328690D0 (en) 2003-12-10 2004-01-14 Ludwig Inst Cancer Res Tumour suppressor protein
GB0406330D0 (en) * 2004-03-20 2004-04-21 Univ Sheffield Gene screen
GB0509965D0 (en) 2005-05-17 2005-06-22 Ml Lab Plc Improved expression elements
WO2008085962A2 (en) 2007-01-08 2008-07-17 Millipore Corporation Cell culture methods for producing recombinant proteins in the presence of reduced levels of one or more contaminants
DK2571998T3 (en) * 2010-05-19 2017-09-25 Icosagen Cell Factory Oü METHOD AND KIT FOR IDENTIFICATION OF CHEMICAL COMPOUNDS MADE TO INHIBIT HUMAN PAPILLOMA VIRUS REPLICATION
JP5863338B2 (ja) * 2011-08-25 2016-02-16 株式会社東芝 プラスミド型ベクター、遺伝子プロモーター活性の検出方法、及びアッセイキット
EP3137100B1 (en) 2014-04-15 2023-12-20 University Of Virginia Patent Foundation Isolated t cell receptors and methods of use therefor
GB201710973D0 (en) 2017-07-07 2017-08-23 Avacta Life Sciences Ltd Scaffold proteins
WO2020018715A1 (en) 2018-07-17 2020-01-23 Massachusetts Institute Of Technology Soluble multimeric immunoglobulin-scaffold based fusion proteins and uses thereof
SG11202104337PA (en) 2018-11-26 2021-05-28 Massachusetts Inst Technology Compositions and methods for immune tolerance
TW202128775A (zh) 2019-10-16 2021-08-01 英商阿法克塔生命科學有限公司 PD-L1抑制劑-TGFβ抑制劑雙特異性藥物部分
GB202101299D0 (en) 2020-06-09 2021-03-17 Avacta Life Sciences Ltd Diagnostic polypetides and methods
WO2022043686A1 (en) 2020-08-25 2022-03-03 Thrombosis Research Institute Vaccine
GB2606693A (en) 2021-04-08 2022-11-23 Exosis Inc Fusion protein
WO2022234003A1 (en) 2021-05-07 2022-11-10 Avacta Life Sciences Limited Cd33 binding polypeptides with stefin a protein
GB202107057D0 (en) 2021-05-18 2021-06-30 Univ York Glycosylation method
TW202332694A (zh) 2021-10-07 2023-08-16 英商阿凡克塔生命科學公司 血清半衰期延長之ｐｄ－ｌ１結合多肽
TW202334196A (zh) 2021-10-07 2023-09-01 英商阿法克塔生命科學有限公司 Pd-l1結合多肽
WO2023218243A1 (en) 2022-05-12 2023-11-16 Avacta Life Sciences Limited Lag-3/pd-l1 binding fusion proteins

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5173414A (en) * 1990-10-30 1992-12-22 Applied Immune Sciences, Inc. Production of recombinant adeno-associated virus vectors
GB9027917D0 (en) * 1990-12-21 1991-02-13 Ici Plc Expression systems
US5631162A (en) * 1993-06-11 1997-05-20 Massachusetts Institute Of Technology Retroviral vectors for transducing β-globin gene and β-locus control region derivatives
WO1995032299A1 (en) * 1994-05-20 1995-11-30 The Board Of Trustees Of The Leland Stanford Junior University An autonomous replication system for mammalian cells
US6110666A (en) * 1994-06-09 2000-08-29 Medical Research Council Locus control subregions conferring integration-site independent transgene expression abstract of the disclosure
AU4594996A (en) * 1994-11-30 1996-06-19 Chiron Viagene, Inc. Recombinant alphavirus vectors

Also Published As

Publication number Publication date
EP0918874B1 (en) 2001-03-07
JP2000516472A (ja) 2000-12-12
GR3035838T3 (en) 2001-08-31
ATE199570T1 (de) 2001-03-15
DE69704206D1 (de) 2001-04-12
EP0918874A2 (en) 1999-06-02
WO1998007876A3 (en) 1998-04-16
CA2263796A1 (en) 1998-02-26
DE69704206T2 (de) 2001-08-30
ES2157084T3 (es) 2001-08-01
AU725474B2 (en) 2000-10-12
PT918874E (pt) 2001-08-30
WO1998007876A2 (en) 1998-02-26
AU4020997A (en) 1998-03-06

Similar Documents

Publication Publication Date Title
DK0918874T3 (da) Selvreplikerende episomale ekspressionsvektorer, som giver vævsspecifik genekspression
EP1176195A4 (en) METHOD FOR CONTROLLING THE ACTIVITY OF IMMUNOLOGICALLY FUNCTIONAL MOLECULE
EP0677870A3 (en) Controlled etching of oxides using a gas phase process.
EP1182529A3 (de) Industrielle Steuerung auf der Basis Technologischer Objekte
PT805822E (pt) Eritropoietina seca por pulverizacao
AU6421399A (en) Interpretive language architecture for controlling the attributes of a physical,chemical, or thermodynamic process
EP1143004A3 (en) Bacillus thuringiensis microbes active against nematodes, and genes encoding novel nematode-active toxins cloned from bacillus thuringiensis isolates
DE69726194D1 (de) Ds11 (kctc 02311bp), neuartiger bacillus sp. stamm und neue von diesem produzierte phytase
ZA976559B (en) Method for activation of bleaches.
DE69818097D1 (de) Rückkopplungdruck- regelsystem für gleitringdichtung
TW359059B (en) Method and arrangement for encoding a video signal
YU59604A (sh) Fibrinolitički aktivan polipeptid
AU2678195A (en) Locus control subregions for integration-site independent transgene expression
GB2305265A8 (en) System for simplifying the operation of control functions
EP0598133A4 (en) Wound medication.
EP0654725A3 (en) Mechanism for controlling the position of levers.
ES2169404T3 (es) Guia de cajon, diferencial super-extensible.
AU689803B2 (en) Plant-derived phospholipase D gene
EP0678905A3 (en) Joint for controlling the dissolution of a wafer in a micromachining process.
ES2188899T3 (es) Agente antifungico.
IT1295436B1 (it) Valvola di controllo.
AU2001234862A1 (en) Interface assembly for lapping control feedback
FI941394A (fi) Peptidejä,jotka kykenevät säätelemään akrosomireaktiota
ES2149353T3 (es) Polimorfos a y b de 1-(difenilmetil)-4-(3-(2-fenil-1,3-dioxolan-2-il)propil)piperazina.
ZA9834B (en) Method for the control of resistant population of lepidoptera.